Tramadol Induces Neuroinflammation, Mitochondrial Oxidative Stress, Neurotransmitters Dysbalanced and Produced Parkinson’s Disease Like Symptoms in Experimental Wistar Rats
Objective: The current study is designed to evaluate the possible neurotoxic effects of tramadol in Wistar rats. Background: Parkinson’s disease (PD) is a chronic neurodegenerative…Asymmetry of striatal dopaminergic function in essential tremor is associated with kinetic tremor asymmetry
Objective: To investigate possible dopaminergic pathophysiology of essential tremor (ET) by focusing on tremor asymmetry. Background: Essential tremor (ET) is considered a non-dopaminergic movement disorder.…Effect of dietary caffeine on brain dopamine transporter binding in Parkinson’s disease
Objective: To investigate the relationship between dietary caffeine intake and striatal dopamine function over the progression of Parkinson’s disease (PD). Background: The association between high…Dopaminergic Denervation as Predictors of Falls in PD Patients
Objective: We aimed to predict fall risk in PD patients using SBR data obtained from PPMI. Background: While dopamine is currently considered to be the…Continuous circadian intracerebroventricular administration of anaerobically preserved dopamine greatly reduces severe L-dopa-related complications in Parkinson’s disease
Objective: We aim to demonstrate the safety and efficacy of continuous circadian intracerebroventricular (i.c.v.) administration of anaerobic-dopamine (A-dopamine) to reduce the L-dopa-related complications (LDRC) in…The agreement between automated and expert FOG annotations during an at-home protocol: influence of dopaminergic medication and task
Objective: To investigate agreement between a recent automated FOG detection algorithm and expert video ratings, and the influence of dopaminergic medication and task context. Background:…Gray matter volume of proposed brain-first and body-first Parkinson’s disease subtypes
Objective: The aim of this study was to test if markers of the brain-first Parkinson’s disease (PD) subtype are associated with a greater or more…Therapeutic potential of luteolin in manganese induced Parkinson’s disease: Targeting neuroinflammation and oxidative stress.
Objective: To investigate the neurodegenerative facets of Manganese (Mn) in rat model in rat model of Parkinson's disease.To study the neuroprotective effect of luteolin in…Long non-coding RNAs in Parkinson’s disease: bringing back life to the grey matter?
Objective: Our study aims to discover and delineate the role of novel long non-coding RNAs (lncRNAs) in Parkinson’s disease (PD). Background: LncRNAs have been widely…Dynamic functional connectivity changes and striatal dopamine deficiency in Parkinson’s disease
Objective: Using a multimodal neuroimaging approach, we assessed whether striatal dopamine synthesis capacity modulates the temporal dynamics of FC in PD. Background: The novel approach…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 26
- Next Page »